Safety and immunogenicity of ChAdOx1 nCoV-19 (AZD1222) vaccine in adults in Kenya: a phase 1/2 single-blind, randomised controlled trial
Journal article published in 2023 by
Mainga Hamaluba 
,
Samuel Sang,
Benedict Orindi,
Irene Njau,
Henry Karanja,
Naomi Kamau,
John N. Gitonga,
Daisy Mugo,
Daniel Wright,
James Nyagwange,
Bernadette Kutima,
Donwilliams Omuoyo,
Mwaganyuma Mwatasa,
Caroline Ngetsa,
Charles Agoti
and other authors.
,
Samuel Sang,
Benedict Orindi,
Irene Njau,
Henry Karanja,
Naomi Kamau,
John N. Gitonga,
Daisy Mugo,
Daniel Wright,
James Nyagwange,
Bernadette Kutima,
Donwilliams Omuoyo,
Mwaganyuma Mwatasa,
Caroline Ngetsa,
Charles Agoti
and other authors.
